A novel homozygous missense mutation in the SH3-binding motif of STAMBP causing microcephaly-capillary malformation syndrome

Ikumi Hori, Fuyuki Miya, Yutaka Negishi, Ayako Hattori, Naoki Ando, Keith A. Boroevich, Nobuhiko Okamoto, Mitsuhiro Kato, Tatsuhiko Tsunoda, Mami Yamasaki, Yonehiro Kanemura, Kenjiro Kosaki, Shinji Saitoh

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Microcephaly-capillary malformation syndrome is a congenital and neurodevelopmental disorder caused by biallelic mutations in the STAMBP gene. Here we identify the novel homozygous mutation located in the SH3 binding motif of STAMBP (NM_006463.4) (c.707C>T: p.Ser236Phe) through whole-exome sequencing. The case patient was a 2-year-old boy showing severe global developmental delay, progressive microcephaly, refractory seizures, dysmorphic facial features, and multiple capillary malformations. Immunoblot analysis of patient-derived lymphoblastoid cell lines (LCLs) revealed a severe reduction in STAMBP expression, indicating that Ser236Phe induces protein instability. STAMBP interacts with the SH3 domain of STAM and transduces downstream signals from the Jaks-STAM complex. The substitution of Ser236Phe found in the case patient was located in the SH3-binding motif, and we propose the mutation may block STAM binding and subsequently induce STAMBP degradation. Contrary to previously reported STAMBP mutations, the Ser236Phe mutation did not lead to constitutive activation of the PI3K-AKT-mTOR pathway in patient-derived LCLs, as indicated by the expression of phosphorylated S6 ribosomal protein, suggesting that it is not the major pathomechanism underlying the disorder in this patient.

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalJournal of Human Genetics
DOIs
Publication statusAccepted/In press - 2018 Jun 15

Fingerprint

Microcephaly
Missense Mutation
Mutation
Ribosomal Protein S6
Exome
Cell Line
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
src Homology Domains
Phosphatidylinositol 3-Kinases
Seizures
Capillary Malformations, Congenital, 1
Genes
Proteins

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

A novel homozygous missense mutation in the SH3-binding motif of STAMBP causing microcephaly-capillary malformation syndrome. / Hori, Ikumi; Miya, Fuyuki; Negishi, Yutaka; Hattori, Ayako; Ando, Naoki; Boroevich, Keith A.; Okamoto, Nobuhiko; Kato, Mitsuhiro; Tsunoda, Tatsuhiko; Yamasaki, Mami; Kanemura, Yonehiro; Kosaki, Kenjiro; Saitoh, Shinji.

In: Journal of Human Genetics, 15.06.2018, p. 1-7.

Research output: Contribution to journalArticle

Hori, I, Miya, F, Negishi, Y, Hattori, A, Ando, N, Boroevich, KA, Okamoto, N, Kato, M, Tsunoda, T, Yamasaki, M, Kanemura, Y, Kosaki, K & Saitoh, S 2018, 'A novel homozygous missense mutation in the SH3-binding motif of STAMBP causing microcephaly-capillary malformation syndrome', Journal of Human Genetics, pp. 1-7. https://doi.org/10.1038/s10038-018-0482-3
Hori, Ikumi ; Miya, Fuyuki ; Negishi, Yutaka ; Hattori, Ayako ; Ando, Naoki ; Boroevich, Keith A. ; Okamoto, Nobuhiko ; Kato, Mitsuhiro ; Tsunoda, Tatsuhiko ; Yamasaki, Mami ; Kanemura, Yonehiro ; Kosaki, Kenjiro ; Saitoh, Shinji. / A novel homozygous missense mutation in the SH3-binding motif of STAMBP causing microcephaly-capillary malformation syndrome. In: Journal of Human Genetics. 2018 ; pp. 1-7.
@article{7d523b4af7cd423899468a39137cefec,
title = "A novel homozygous missense mutation in the SH3-binding motif of STAMBP causing microcephaly-capillary malformation syndrome",
abstract = "Microcephaly-capillary malformation syndrome is a congenital and neurodevelopmental disorder caused by biallelic mutations in the STAMBP gene. Here we identify the novel homozygous mutation located in the SH3 binding motif of STAMBP (NM_006463.4) (c.707C>T: p.Ser236Phe) through whole-exome sequencing. The case patient was a 2-year-old boy showing severe global developmental delay, progressive microcephaly, refractory seizures, dysmorphic facial features, and multiple capillary malformations. Immunoblot analysis of patient-derived lymphoblastoid cell lines (LCLs) revealed a severe reduction in STAMBP expression, indicating that Ser236Phe induces protein instability. STAMBP interacts with the SH3 domain of STAM and transduces downstream signals from the Jaks-STAM complex. The substitution of Ser236Phe found in the case patient was located in the SH3-binding motif, and we propose the mutation may block STAM binding and subsequently induce STAMBP degradation. Contrary to previously reported STAMBP mutations, the Ser236Phe mutation did not lead to constitutive activation of the PI3K-AKT-mTOR pathway in patient-derived LCLs, as indicated by the expression of phosphorylated S6 ribosomal protein, suggesting that it is not the major pathomechanism underlying the disorder in this patient.",
author = "Ikumi Hori and Fuyuki Miya and Yutaka Negishi and Ayako Hattori and Naoki Ando and Boroevich, {Keith A.} and Nobuhiko Okamoto and Mitsuhiro Kato and Tatsuhiko Tsunoda and Mami Yamasaki and Yonehiro Kanemura and Kenjiro Kosaki and Shinji Saitoh",
year = "2018",
month = "6",
day = "15",
doi = "10.1038/s10038-018-0482-3",
language = "English",
pages = "1--7",
journal = "Journal of Human Genetics",
issn = "1434-5161",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - A novel homozygous missense mutation in the SH3-binding motif of STAMBP causing microcephaly-capillary malformation syndrome

AU - Hori, Ikumi

AU - Miya, Fuyuki

AU - Negishi, Yutaka

AU - Hattori, Ayako

AU - Ando, Naoki

AU - Boroevich, Keith A.

AU - Okamoto, Nobuhiko

AU - Kato, Mitsuhiro

AU - Tsunoda, Tatsuhiko

AU - Yamasaki, Mami

AU - Kanemura, Yonehiro

AU - Kosaki, Kenjiro

AU - Saitoh, Shinji

PY - 2018/6/15

Y1 - 2018/6/15

N2 - Microcephaly-capillary malformation syndrome is a congenital and neurodevelopmental disorder caused by biallelic mutations in the STAMBP gene. Here we identify the novel homozygous mutation located in the SH3 binding motif of STAMBP (NM_006463.4) (c.707C>T: p.Ser236Phe) through whole-exome sequencing. The case patient was a 2-year-old boy showing severe global developmental delay, progressive microcephaly, refractory seizures, dysmorphic facial features, and multiple capillary malformations. Immunoblot analysis of patient-derived lymphoblastoid cell lines (LCLs) revealed a severe reduction in STAMBP expression, indicating that Ser236Phe induces protein instability. STAMBP interacts with the SH3 domain of STAM and transduces downstream signals from the Jaks-STAM complex. The substitution of Ser236Phe found in the case patient was located in the SH3-binding motif, and we propose the mutation may block STAM binding and subsequently induce STAMBP degradation. Contrary to previously reported STAMBP mutations, the Ser236Phe mutation did not lead to constitutive activation of the PI3K-AKT-mTOR pathway in patient-derived LCLs, as indicated by the expression of phosphorylated S6 ribosomal protein, suggesting that it is not the major pathomechanism underlying the disorder in this patient.

AB - Microcephaly-capillary malformation syndrome is a congenital and neurodevelopmental disorder caused by biallelic mutations in the STAMBP gene. Here we identify the novel homozygous mutation located in the SH3 binding motif of STAMBP (NM_006463.4) (c.707C>T: p.Ser236Phe) through whole-exome sequencing. The case patient was a 2-year-old boy showing severe global developmental delay, progressive microcephaly, refractory seizures, dysmorphic facial features, and multiple capillary malformations. Immunoblot analysis of patient-derived lymphoblastoid cell lines (LCLs) revealed a severe reduction in STAMBP expression, indicating that Ser236Phe induces protein instability. STAMBP interacts with the SH3 domain of STAM and transduces downstream signals from the Jaks-STAM complex. The substitution of Ser236Phe found in the case patient was located in the SH3-binding motif, and we propose the mutation may block STAM binding and subsequently induce STAMBP degradation. Contrary to previously reported STAMBP mutations, the Ser236Phe mutation did not lead to constitutive activation of the PI3K-AKT-mTOR pathway in patient-derived LCLs, as indicated by the expression of phosphorylated S6 ribosomal protein, suggesting that it is not the major pathomechanism underlying the disorder in this patient.

UR - http://www.scopus.com/inward/record.url?scp=85048539549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048539549&partnerID=8YFLogxK

U2 - 10.1038/s10038-018-0482-3

DO - 10.1038/s10038-018-0482-3

M3 - Article

C2 - 29907875

AN - SCOPUS:85048539549

SP - 1

EP - 7

JO - Journal of Human Genetics

JF - Journal of Human Genetics

SN - 1434-5161

ER -